Combination of IL-1 Receptor Antagonist, IL-20 and CD40 Ligand for the Prediction of Acute Cellular Renal Allograft Rejection
Xiaoguang Xu(The 309th Hospital of Chinese People's Liberation Army), Bingyi Shi(The 309th Hospital of Chinese People's Liberation Army), Yong Han(Shanghai Jiao Tong University), Xiao Li(The 309th Hospital of Chinese People's Liberation Army), Ming Cai(The 309th Hospital of Chinese People's Liberation Army), Wenqiang Zhou(Fujian University of Traditional Chinese Medicine), Hongwei Bai(The 309th Hospital of Chinese People's Liberation Army), Yeyong Qian(The 309th Hospital of Chinese People's Liberation Army), Zhouli Li(The 309th Hospital of Chinese People's Liberation Army), Xinying Wang(The 309th Hospital of Chinese People's Liberation Army), Haiyan Huang(The 309th Hospital of Chinese People's Liberation Army)
Cited by 17
Related Papers
Synergistic activation of p53 by inhibition of <i>MDM2</i> expression and DNA damage
|Proceedings of the National Academy of Sciences|1998|161
Analysis of Mucosal Melanoma Whole-Genome Landscapes Reveals Clinically Relevant Genomic Aberrations
|Clinical Cancer Research|2019|128
Ubiquitous Induction of p53 in Tumor Cells by Antisense Inhibition of MDM2 Expression
|Molecular Medicine|1999|76
Asymmetric Total Synthesis of Sarpagine and Koumine Alkaloids
|Angewandte Chemie International Edition|2021|53
Targeting LSD1 suppresses stem cell-like properties and sensitizes head and neck squamous cell carcinoma to PD-1 blockade
|Cell Death and Disease|2021|41